posted on 2024-02-14, 08:03authored byPatcharee Pripdeevech, Sarunpron Khruengsai, Chutima Tanapichatsakul, Wael M. Afifi, Winnie Chemutai Sum, Kevin D. Hyde, Sherif S. Ebada
Fungal-derived
natural products continue to play a pivotal role
in the discovery of drug agents for human, veterinary, and general
agricultural use. The fungus Neodidymelliopsis negundinis presents a significant saprobic ascomycete whose metabolites remained
hitherto unstudied. Herein we report the isolation of eight unprecedented
secondary metabolites named neodidymelliosides A and B (1 and 2), neodidymelliol A (3), and neodidymellioic
acids A–E (4–8) produced by
the submerged cultures of the fungus. Compound 1 proved
to be the most active compound, with IC50 values ranging
between 4.8 and 8.8 μM against KB3.1 (cervix), PC-3 (prostate),
MCF-7 (breast), SKOV-3 (ovary), A431 (skin), and A549 (lung) cell
lines. Compound 1 revealed significant inhibition of Staphylococcus aureus and Candida albicans biofilms.